{
    "nctId": "NCT02538484",
    "briefTitle": "Impact of Omega 3 Fatty Acid Supplementation on Aromatase in Obese Subjects",
    "officialTitle": "A Phase 0, Investigator Initiated Study, Evaluating the Impact of Omega 3 Fatty Acid Supplementation on Aromatase in Obese Postmenopausal Women With Estrogen Receptor Positive Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "EARLY_PHASE1",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "BASIC_SCIENCE",
    "enrollmentCount": 24,
    "primaryOutcomeMeasure": "Change in levels of aromatase target gene.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* At least 18 years of age.\n* Postmenopausal as confirmed in medical history\n* Ability to understand the purposes and risks of the study and has signed a written informed consent form approved by the investigator's IRB (Institutional Review Board)/Ethics Committee.\n* Estrogen receptor positive breast cancer. Body mass index of 30 or greater.\n* Consented for tissue collection on CTRC (Cancer Therapy and Research Center) repository 07-32\n\nExclusion Criteria:\n\n* Cachexia\n* Active systemic illness (infection including viral illnesses such as Hepatitis and HIV)\n* Chronic use of NSAIDs (nonsteroidal anti-inflammatory drugs) aspirin or omega-3 free fatty acid supplementation within the last 60 days (defined as greater than or equal to 7 consecutive days)\n* Any NSAIDs aspirin or omega-3 free fatty acid supplementation within the last 14 days\n* History of medical noncompliance\n* Scheduled date of surgical resection that would limit the amount of time taking the intervention to less than 21 days",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}